BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 9730461)

  • 21. The effect of dutasteride on the peripheral and transition zones of the prostate and the value of the transition zone index in predicting treatment response.
    Marks LS; Roehrborn CG; Wolford E; Wilson TH
    J Urol; 2007 Apr; 177(4):1408-13. PubMed ID: 17382742
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Risk factors for lower urinary tract symptoms suggestive of benign prostatic hyperplasia in a community based population of healthy aging men: the Krimpen Study.
    Kok ET; Schouten BW; Bohnen AM; Groeneveld FP; Thomas S; Bosch JL
    J Urol; 2009 Feb; 181(2):710-6. PubMed ID: 19091352
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The correlation between prostate volume, transition zone volume, transition zone index and clinical and urodynamic investigations in patients with lower urinary tract symptoms.
    Witjes WP; Aarnink RG; Ezz-el-Din K; Wijkstra H; Debruyne EM; de la Rosette JJ
    Br J Urol; 1997 Jul; 80(1):84-90. PubMed ID: 9240186
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Determination of transition zone volume by transrectal ultrasound in patients with clinically benign prostatic hyperplasia: agreement with enucleated prostate adenoma weight.
    Baltaci S; Yagci C; Aksoy H; Elan AH; Gögüs O
    J Urol; 2000 Jul; 164(1):72-5. PubMed ID: 10841600
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A randomized trial comparing holmium laser enucleation of the prostate with transurethral resection of the prostate for the treatment of bladder outlet obstruction secondary to benign prostatic hyperplasia in large glands (40 to 200 grams).
    Tan AH; Gilling PJ; Kennett KM; Frampton C; Westenberg AM; Fraundorfer MR
    J Urol; 2003 Oct; 170(4 Pt 1):1270-4. PubMed ID: 14501739
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Resistive index as risk factor for acute urinary retention in patients with benign prostatic hyperplasia.
    Shinbo H; Kurita Y; Takada S; Imanishi T; Otsuka A; Furuse H; Nakanishi T; Mugiya S; Ozono S
    Urology; 2010 Dec; 76(6):1440-5. PubMed ID: 20646746
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prostate shape and symptom score in benign prostatic hyperplasia.
    Lee T; Seong DH; Yoon SM; Ryu JK
    Yonsei Med J; 2001 Oct; 42(5):532-8. PubMed ID: 11675682
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ultrasound image features of intravesical prostatic protrusion indicated failure of medication therapy of finasteride and doxazosin in patients with benign prostatic hyperplasia (LUTS/BPH).
    Liu Q; Zhu Y; Liu J; Qi J; Kang J
    Int Urol Nephrol; 2017 Mar; 49(3):399-404. PubMed ID: 27987130
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of dutasteride on storage and voiding symptoms in male patients with lower urinary tract symptoms as a result of benign prostatic obstruction: the 1-year outcomes from a prospective urodynamic study.
    Matsukawa Y; Gotoh M; Kato M; Funahashi Y; Narita M; Mitsui K
    Int J Urol; 2014 Aug; 21(8):826-30. PubMed ID: 24661225
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Decreased urinary nerve growth factor reflects prostatic volume reduction and relief of outlet obstruction in patients with benign prostatic enlargement treated with dutasteride.
    Wada N; Matsumoto S; Kita M; Hashizume K; Kakizaki H
    Int J Urol; 2014 Dec; 21(12):1258-62. PubMed ID: 25039474
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analysis of suprapubic and transrectal measurements in assessment of prostate dimensions and volume: is transrectal ultrasonography really necessary for prostate measurements?
    Ozden E; Göğüş C; Kiliç O; Yaman O; Ozdiler E
    Urol J; 2009; 6(3):208-13. PubMed ID: 19711277
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of holmium laser enucleation of prostate on overactive bladder symptoms and urodynamic parameters: a prospective study.
    Kwon O; Lee HE; Bae J; Oh JK; Oh SJ
    Urology; 2014 Mar; 83(3):581-5. PubMed ID: 24373317
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transition zone ratio and prostate-specific antigen density as predictors of the response of benign prostatic hypertrophy to alpha blocker and anti-androgen therapy.
    Kurita Y; Masuda H; Suzuki K; Fujita K; Kawabe K
    Br J Urol; 1997 Jul; 80(1):78-83. PubMed ID: 9240185
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Urodynamic effects of transrectal intraprostatic Ona botulinum toxin A injections for symptomatic benign prostatic hyperplasia.
    de Kort LM; Kok ET; Jonges TN; Rosier PF; Bosch JL
    Urology; 2012 Oct; 80(4):889-93. PubMed ID: 22854138
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transition zone volume and transition zone ratio: predictor of uroflow response to finasteride therapy in benign prostatic hyperplasia patients.
    Tewari A; Shinohara K; Narayan P
    Urology; 1995 Feb; 45(2):258-64; discussion 265. PubMed ID: 7531900
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Holmium laser enucleation versus photoselective vaporization for prostatic adenoma greater than 60 ml: preliminary results of a prospective, randomized clinical trial.
    Elmansy H; Baazeem A; Kotb A; Badawy H; Riad E; Emran A; Elhilali M
    J Urol; 2012 Jul; 188(1):216-21. PubMed ID: 22591968
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transrectal ultrasonic planimetry of the prostate in relation to age and lower urinary tract symptoms among elderly men in Japan.
    Taneike R; Kojima M; Saitoh M
    Tohoku J Exp Med; 1997 Oct; 183(2):135-50. PubMed ID: 9526804
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vitamin D Deficiency as a Potential Marker of Benign Prostatic Hyperplasia.
    Zhang W; Zheng X; Wang Y; Xiao H
    Urology; 2016 Nov; 97():212-218. PubMed ID: 27327576
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The value of symptom score, quality of life score, maximal urinary flow rate, residual volume and prostate size for the diagnosis of obstructive benign prostatic hyperplasia: a urodynamic analysis.
    van Venrooij GE; Boon TA
    J Urol; 1996 Jun; 155(6):2014-8. PubMed ID: 8618311
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Symptoms and quality of life versus age, prostate volume, and urodynamic parameters in 565 strictly selected men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia.
    Eckhardt MD; van Venrooij GE; Boon TA
    Urology; 2001 Apr; 57(4):695-700. PubMed ID: 11306383
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.